PLUR
PLUR clinical trials: Pluri Inc.
Every trial on ClinicalTrials.gov where Pluri Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 11
- Trials linked
- 11
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PLUR on the catalyst calendar · PLUR registry changes
- Primary completion Not registeredNo phase registeredNCT03886506Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for RevascularizationPluristem Ltd. · Critical Limb Ischemia (CLI)No longer availablePLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 17, 2021ActualPhase 2NCT04389450Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19Pluristem Ltd. · COVIDTerminatedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 3, 2021ActualPhase 3NCT03006770Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI)...Pluristem Ltd. · Critical Limb Ischemia (CLI)CompletedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 4, 2021ActualPhase 2NCT04614025Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19Pluristem Ltd. · COVIDTerminatedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 29, 2022ActualPhase 3NCT03451916Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)Pluristem Ltd. · Hip FractureCompletedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2021ActualPhase 1NCT03002519Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell...Pluristem Ltd. · Incomplete HCT (Hematopoietic Cell Transplantation)CompletedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2021Sponsor estimatePhase 1NCT03797040Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic...Pluristem Ltd. · Ionizing Radiation ExposureUnknown statusPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 29, 2018ActualPhase 2NCT01679990Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)Pluristem Ltd. · Intermittent ClaudicationCompletedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2013ActualPhase 1/Phase 2NCT01525667Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip ArthroplastyPluristem Ltd. · Total Hip ArthroplastyCompletedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2011ActualPhase 1NCT00951210Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)Pluristem Ltd. · Peripheral Artery DiseaseCompletedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2012ActualPhase 1NCT00919958Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb IschemiaPluristem Ltd. · Peripheral Artery DiseaseCompletedPLURLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 11 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner